Patient Guide: A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants in Japan With Alopecia Areata

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 12 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT07023302
Status: 🟢 Enrolling Now
Condition: Alopecia Areata
Phase: PHASE3

Where You Can Participate

This study is available at 12 locations across the country.

Top locations include:
  • • Nagoya, Aichi
  • • Kurume-shi, Fukuoka
  • • Kahoku-gun, Ishikawa
  • • And 9 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants in Japan With Alopecia Areata - Join Clinical Trial NCTNCT07023302

How to Join This Clinical Trial - NCTNCT07023302

Learn how to participate in this PHASE3 trial studying an investigational therapy for Alopecia Areata. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Alopecia Areata. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Alopecia Areata
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT07023302 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 12 locations. Find a study site near you:

Clinical Research Site

Nagoya, Aichi 467-8602 - Japan

Status: RECRUITING

Clinical Research Site

Kurume-shi, Fukuoka 830-0011 - Japan

Status: RECRUITING

Clinical Research Site

Kahoku-gun, Ishikawa 920-0265 - Japan

Status: RECRUITING

Clinical Research Site

Ebina-shi, Kanagawa 243-0432 - Japan

Status: RECRUITING

Clinical Research Site

Miyagi-gun, Miyagi 981-0112 - Japan

Status: RECRUITING

Clinical Research Site

Niigata-shi, Niigata 951-8520 - Japan

Status: RECRUITING

Clinical Research Site

Osaka-shi, Osaka 542-0081 - Japan

Status: RECRUITING

Clinical Research Site

Osaka-shi, Osaka 545-8586 - Japan

Status: RECRUITING

Clinical Research Site

Shinjuku-ku, Tokyo 160-0023 - Japan

Status: RECRUITING

Clinical Research Site

Shinjuku-ku, Tokyo 160-8582 - Japan

Status: RECRUITING

And 2 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Alopecia Areata:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships